This study plans to learn more about cannabidiol (CBD) as a potential treatment in patients that have Traumatic Brain Injury (TBI)-related symptoms. CBD is a chemical found in the cannabis (or hemp) plant that can be used as a medication.
Our study is seeking individuals aged 18-60, who have been diagnosed with a traumatic brain injury (TBI). The goal of the study is to see whether cannabinoids (CBD) can improve TBI symptoms.
Main study tasks include blood draws, urine pregnancy and drug screening, questionnaires, and cognitive tests.
Your participation in this study will be 12 weeks, with 12 weeks of study medication use.
1. Between the ages of 18-60 2. Diagnosed with a traumatic brain injury (TBI) 3. Interested in using cannabidiol (CBD) for TBI symptoms
Protocol Number: 22-1427
More information available at ClinicalTrials.gov: NCT05632627
220
Principal Investigator